These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 454204)

  • 1. Malignant hyperthermia.
    Blanck TJ; Gruener R; Casey WJ; Stern LZ
    Ariz Med; 1979 May; 36(5):351-3. PubMed ID: 454204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peroperative disclosure of a case of malignant hyperthermia. Elements of suspicion of the diagnosis, in vitro study of the sensitivity of muscle fibers].
    Brasdefer D; Cantineau D; Tassin M; Krivosic-Horber R; Scherpereel P
    Cah Anesthesiol; 1988; 36(2):149-51. PubMed ID: 3365590
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion.
    Nelson TE; Flewellen EH
    Tex Rep Biol Med; 1979; 38():105-20. PubMed ID: 531756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia.
    Tollefson G
    J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current data on the screening of malignant hyperthermia during anesthesia].
    Krivosic-Horber R; Adnet P
    Chirurgie; 1993-1994; 119(1-2):55-8. PubMed ID: 7995103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive tests for malignant hyperpyrexia.
    Isaacs H; Heffron JJ; Badenhorst M
    Br J Anaesth; 1975 Oct; 47(10):1075-80. PubMed ID: 128373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia in China.
    Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
    Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plasma membrane defect of skeletal muscle in malignant hyperthermia.
    Gallant EM; Godt RE; Gronert GA
    Muscle Nerve; 1979; 2(6):491-4. PubMed ID: 514315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro determination of susceptibility to malignant hyperthermia.
    Iaizzo PA; Lehmann-Horn F
    Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperpyrexia.
    Ellis FR
    Anaesthesia; 1973 May; 28(3):245-52. PubMed ID: 4713948
    [No Abstract]   [Full Text] [Related]  

  • 12. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant malignant hyperthermia.
    Bross T; Steinmann D
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):164-5. PubMed ID: 18173438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia suggestive hypermetabolic syndrome at emergence from anesthesia.
    Christiaens F; Gepts E; D'Haese J; Camu F
    Acta Anaesthesiol Belg; 1995; 46(2):93-7. PubMed ID: 8714856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current diagnostic methods of malignant hyperthermia: an evaluation.
    Ording H
    Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
    [No Abstract]   [Full Text] [Related]  

  • 19. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
    Larach MG
    Anesth Analg; 1989 Oct; 69(4):511-5. PubMed ID: 2675676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.